A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus
Clinical trial NCT05140824 · TERMINATED
Trial details
- NCT number
- NCT05140824
- Sponsor
- TJ Biopharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2022-12-14
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.